Testing HR+ / HER2-patients with advanced or metastatic breast cancer for identification of tissue mutations in the PIK3CA gene: Results of a national program by the Hellenic Society of Medical Oncology (HeSMO)

被引：0
|
作者：
Boutis, A. [1 ]
Nikolaou, M. [1 ]
Ardavanis, A. [1 ]
Tolis, C. [1 ]
Loga, K. [1 ]
Korantzis, I. [1 ]
Koumarianou, A. [1 ]
Christopoulou, A. N. [1 ]
Papatsimpas, G. [1 ]
Bokas, A. [1 ]
Pliarchopoulou, K. [1 ]
Kampletsas, E. [1 ]
Kesisis, G. [1 ]
Biziota, E. [1 ]
Psianou, K. [1 ]
Karageorgopoulou, S. [1 ]
Sogka, E. A. [1 ]
Tsoukalas, N. G. [1 ]
Chatzifoti, N. [1 ]
Saridaki-Zoras, Z. [1 ]
机构：
[1] Hellenic Soc Med Oncol, HeSMO, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439P
引用
收藏
页码：S366 / S366
页数：1
相关论文
共 50 条
  • [21] Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study
    Papaxoinis, George
    Kotoula, Vassiliki
    Alexopoulou, Zoi
    Kalogeras, Konstantine T.
    Zagouri, Flora
    Timotheadou, Eleni
    Gogas, Helen
    Pentheroudakis, George
    Christodoulou, Christos
    Koutras, Angelos
    Bafaloukos, Dimitrios
    Aravantinos, Gerasimos
    Papakostas, Pavlos
    Charalambous, Elpida
    Papadopoulou, Kyriaki
    Varthalitis, Ioannis
    Efstratiou, Ioannis
    Zaramboukas, Thomas
    Patsea, Helen
    Scopa, Chrisoula D.
    Skondra, Maria
    Kosmidis, Paris
    Pectasides, Dimitrios
    Fountzilas, George
    PLOS ONE, 2015, 10 (10):
  • [22] CURRENT AND FUTURE MANAGEMENT OF PATIENTS WITH ADVANCED HR+HER2-ABC WITH PIK3CA MUTATIONS IN THE UK: THE PIK PATHWAY UK PROJECT
    Winter, Matthew
    de Castro, David Gonzalez
    Askham, Jonathan
    BREAST, 2021, 59 : S47 - S47
  • [23] Frequent germline BRCA1/2 mutations in women with ovarian cancer and the need for insurance coverage of genetic testing: A Hellenic Society of Medical Oncology (HeSMO) national program.
    Lypas, Georgios
    Saridaki, Zacharenia
    Saloustros, Emmanouil S.
    Liontos, Michael
    Bournakis, Evangelos
    Papandreou, Christos
    Lianos, Evangelos
    Kalofonos, Haralabos
    Maragouli, Elena
    Aravantinos, Gerasimos
    Xenidis, Nikolaos
    Andreadis, Charalampos
    Stergiou, Eleni
    Bokas, Alexandros
    Gouedard, Cedric
    Nasioulas, George
    Papageorgiou, Fotini
    Athanasiadis, Athanasios
    Varthalitis, Ioannis
    Boukovinas, Ioannis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Significance of PIK3CA mutations in patients with early breast cancer treated with adjuvant chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) study
    Papaxoinis, G.
    Kotoula, V.
    Alexopoulou, Z.
    Charalambous, E.
    Zagouri, F.
    Timotheadou, E.
    Gogas, H.
    Pentheroudakis, G.
    Koutras, A.
    Christodoulou, C.
    Bafaloukos, D.
    Aravantinos, G.
    Kalogeras, K. T.
    Pectasides, D.
    Fountzilas, G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S325 - S326
  • [25] Screening of colorectal cancer (CRC) patients for lynch syndrome (LS) emphasizes the need for public insurance coverage of genetic testing: Results of a national program by the Hellenic Society of Medical Oncology (HeSMO).
    Saridaki, Zacharenia
    Saloustros, Emmanouil S.
    Tsoukalas, Nikolaos
    Makatsoris, Thomas
    Lypas, Georgios
    Kalofonos, Haralabos
    Christopoulou, Athina
    Bompolaki, Iliada
    Sougklakos, Ioannis
    Voulgaris, Evangelos
    Karampeazis, Athanasios
    Papandreou, Christos
    Anagnostopoulos, Athanasios
    Galani, Eleni P.
    Ballasis, Konstantinos
    Zagouri, Flora
    Rizos, Georgios
    Athanasiadis, Athanasios
    Varthalitis, Ioannis I.
    Boukovinas, Ioannis
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project
    Peixoto, Ana
    Cirnes, Luis
    Carvalho, Ana Luisa
    Andrade, Maria Joao
    Brito, Maria Jose
    Borralho, Paula
    Borralho, Pedro M.
    Carneiro, Ana Sofia
    Castro, Lisandra
    Correia, Lurdes
    Dionisio, Maria Rita
    Faria, Carlos
    Figueiredo, Paulo
    Gomes, Ana
    Paixao, Joana
    Pinheiro, Manuela
    Prazeres, Hugo
    Ribeiro, Joana
    Salgueiro, Natalia
    Schmitt, Fernando C.
    Silva, Fatima
    Silvestre, Ana Rita
    Sousa, Ana Carla
    Almeida-Tavares, Joana
    Teixeira, Manuel R.
    Andre, Saudade
    Machado, Jose Carlos
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [27] COST-EFFECTIVENESS OF ALPELISIB PLUS FULVESTRANT FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH PIK3CA MUTANT, HR+/HER2-ADVANCED BREAST CANCER IN TURKEY
    Tatar, M.
    Akgul, T.
    Ozbalas, T.
    Yuzgenc, Z.
    Cilingiroglu, M.
    VALUE IN HEALTH, 2022, 25 (12) : S133 - S133
  • [28] Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project
    Peixoto, Ana
    Cirnes, Luis
    Carvalho, Ana Luisa
    Andrade, Maria Joao
    Brito, Maria Jose
    Borralho, Paula
    Coimbra, Nuno
    Borralho, Pedro M.
    Carneiro, Ana Sofia
    Castro, Lisandra
    Correia, Lurdes
    Dionisio, Maria Rita
    Faria, Carlos
    Figueiredo, Paulo
    Gomes, Ana
    Paixao, Joana
    Pinheiro, Manuela
    Prazeres, Hugo
    Ribeiro, Joana
    Salgueiro, Natalia
    Schmitt, Fernando C.
    Silva, Fatima
    Silvestre, Ana Rita
    Sousa, Ana Carla
    Almeida-Tavares, Joana
    Teixeira, Manuel R.
    Andre, Saudade
    Machado, Jose Carlos
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [29] Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) in patients with HR-positive (HR+)/HER2-negative (HER2-) advanced breast cancer (ABC) with PIK3CA mutations (m) in routine practice at several Russian centers
    Zhukova, Lyudmila
    Filonenko, Daria
    Grechukhina, Katerina
    Stepanchencko, Margarita
    Orlova, Rashida
    Gluzman, Mark
    Vakhitova, Almira
    Goryainova, Alla
    Fedyanin, Mikhail
    Glazkova, Elena
    Stroyakovsky, Daniil
    Danilova, Anastasia
    Pokataev, Ilya
    Stativko, Olesia
    Andreyashkina, Irina
    Trotsenko, Ivan
    Khatkov, Igor
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab
    Cizkova, M.
    Dujaric, M-E
    Lehmann-Che, J.
    Scott, V.
    Tembo, O.
    Asselain, B.
    Pierga, J-Y
    Marty, M.
    de Cremoux, P.
    Spyratos, F.
    Bieche, I.
    BRITISH JOURNAL OF CANCER, 2013, 108 (09) : 1807 - 1809
12345